Physician profile
Martha Carr
NPI 1093779522
$3,679.44
in general payments reported to CMS, 2019-2025
23 companies · $270 in 2025
The $270 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $707 · 2020: $360 · 2021: $629 · 2022: $411 · 2023: $786 · 2024: $516 · 2025: $270.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,172 · Education: $400.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,172.24 |
| Education | $399.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $854.10 | 2021-2025 | Azure Xt Dr Mri Surescan, Linq II, Selectsecure |
| Astrazeneca Pharmaceuticals LP | $399.96 | 2023 | Brilinta |
| Abiomed | $393.83 | 2019-2020 | |
| Medtronic Vascular, INC. | $307.58 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $286.87 | 2019-2025 | Camzyos, Eliquis |
| Kestra Medical Technology Services, INC. | $188.60 | 2022-2025 | Assure Wcd |
| Sanofi-Aventis U.S. LLC | $171.84 | 2019-2023 | |
| Abbott Laboratories | $155.69 | 2019-2023 | Assurity |
| Pfizer INC. | $154.19 | 2020-2023 | |
| Boston Scientific Corporation | $144.83 | 2019-2024 | Rotapro, Bodyguardian |
| Novo Nordisk INC | $118.76 | 2023-2025 | Wegovy, Ozempic |
| Baxter Healthcare | $112.42 | 2023-2024 | Hillrom - Carnation Ambulatory Monitor |
| Zimmer Biomet Holdings, INC. | $103.39 | 2021 | |
| Silk Road Medical, INC. | $91.23 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter, Enroute Transcarotid Stent |
| Regeneron Healthcare Solutions, INC. | $36.43 | 2024 | Evkeeza |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $31.93 | 2019-2023 | Lifevest |
| Lundbeck LLC | $23.26 | 2019 | |
| Astellas Pharma US INC | $19.92 | 2019 | |
| Tactile Systems Technology INC | $18.89 | 2024 | Flexitouch Plus, Entre Plus |
| Scpharmaceuticals INC. | $17.28 | 2025 | |
| Cook Medical LLC | $17.22 | 2025 | Zilver Ptx |
| Novartis Pharmaceuticals Corporation | $16.23 | 2024 | |
| Smith+Nephew, INC. | $14.99 | 2023 | Pico 7 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Martha Carr listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.